Page last updated: 2024-09-05

sb 203580 and Hypercapnia

sb 203580 has been researched along with Hypercapnia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, LJ; Ma, YC; Wang, WT; Wang, YY; Ying, L; Zheng, MX1
Armstead, WM; Cines, DB; Higazi, AA; Kiessling, JW; Riley, J1

Other Studies

2 other study(ies) available for sb 203580 and Hypercapnia

ArticleYear
[Expression of KATP in pulmonary artery smooth muscle cells under hypoxia-hypercapnia condition and the relationship with p38 MAPK pathway].
    Sheng li xue bao : [Acta physiologica Sinica], 2014, Jun-25, Volume: 66, Issue:3

    Topics: Animals; Anisomycin; Cell Hypoxia; Cells, Cultured; Hypercapnia; Imidazoles; KATP Channels; Male; MAP Kinase Signaling System; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Pulmonary Artery; Pyridines; Rats; Rats, Sprague-Dawley; Sulfonylurea Receptors

2014
PAI-1-derived peptide EEIIMD prevents impairment of cerebrovasodilation by augmenting p38 MAPK upregulation after cerebral hypoxia/ischemia.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:1

    Topics: Animals; Animals, Newborn; Anthracenes; Blood Pressure; Carbon Dioxide; Cardiovascular Agents; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Female; Hypercapnia; Hypotension; Hypoxia-Ischemia, Brain; Imidazoles; Injections, Intravenous; Isoproterenol; JNK Mitogen-Activated Protein Kinases; Male; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pia Mater; Protein Kinase Inhibitors; Pyridines; Swine; Time Factors; Up-Regulation; Vasodilation; Vasodilator Agents

2010